A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E

被引:10
|
作者
Watanabe, Tomoko [1 ]
Takeda, Ko [2 ]
Hiemori, Keiko [1 ]
Minamisawa, Toshikazu [2 ]
Tateno, Hiroaki [1 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan
[2] Seikagaku Corp, Cent Res Lab, Higashiyamato, Japan
关键词
chondroitin sulfate; glycosaminoglycan; heparan sulfate; microarray; S protein; SARS-CoV-2; GROWTH-FACTORS; INVASION; HEPARIN; CELLS;
D O I
10.1002/1873-3468.14173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparan sulfate (HS), a sulfated glycosaminoglycan (GAG), was reported to be a necessary host attachment factor that promotes SARS-CoV-2 infection. In this study, we developed GAG microarrays based on fluorescence detection for high-sensitivity screening of the GAG-binding specificity of proteins and applied it for the analysis of SARS-CoV-2 spike (S) protein. Among the 20 distinct GAGs, the S protein bound not only to heparin (HEP)/HS but also to chondroitin sulfate E (CSE) in a concentration-dependent manner. We then analyzed the specificity of each subunit of the S protein. While the S1 subunit showed exclusive binding to HEP, the S2 subunit also bound to CSE and HEP/HS. CSE might act as an alternative attachment factor for HS in SARS-CoV-2 infection.
引用
收藏
页码:2341 / 2349
页数:9
相关论文
共 50 条
  • [21] Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding
    Scheiblhofer, Sandra
    Drothler, Stephan
    Braun, Werner
    Braun, Reinhard
    Boesch, Maximilian
    Weiss, Richard
    VACCINE, 2021, 39 (32) : 4399 - 4403
  • [22] Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
    Yue, Jingwen
    Jin, Weihua
    Yang, Hua
    Faulkner, John
    Song, Xuehong
    Qiu, Hong
    Teng, Michael
    Azadi, Parastoo
    Zhang, Fuming
    Linhardt, Robert J.
    Wang, Lianchun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [23] Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
    Beaudoin, Christopher A.
    Hamaia, Samir W.
    Huang, Christopher L. -H.
    Blundell, Tom L.
    Jackson, Antony P.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [24] Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
    Deepali Gupta
    Priyanka Sharma
    Mandeep Singh
    Mukesh Kumar
    A. S. Ethayathulla
    Punit Kaur
    Cellular and Molecular Life Sciences, 2021, 78 : 7967 - 7989
  • [25] Is there an interplay between the SARS-CoV-2 spike protein and Platelet-Activating factor?
    Antonopoulou, Smaragdi
    Petsini, Filio
    Detopoulou, Maria
    Theoharides, Theoharis C.
    Demopoulos, Constantinos A.
    BIOFACTORS, 2022, 48 (06) : 1271 - 1283
  • [26] An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
    Liu, Yafei
    Soh, Wai Tuck
    Kishikawa, Jun-ichi
    Hirose, Mika
    Nakayama, Emi E.
    Li, Songling
    Sasai, Miwa
    Suzuki, Tatsuya
    Tada, Asa
    Arakawa, Akemi
    Matsuoka, Sumiko
    Akamatsu, Kanako
    Matsuda, Makoto
    Ono, Chikako
    Torii, Shiho
    Kishida, Kazuki
    Jin, Hui
    Nakai, Wataru
    Arase, Noriko
    Nakagawa, Atsushi
    Matsumoto, Maki
    Nakazaki, Yukoh
    Shindo, Yasuhiro
    Kohyama, Masako
    Tomii, Keisuke
    Ohmura, Koichiro
    Ohshima, Shiro
    Okamoto, Toru
    Yamamoto, Masahiro
    Nakagami, Hironori
    Matsuura, Yoshiharu
    Nakagawa, Atsushi
    Kato, Takayuki
    Okada, Masato
    Standley, Daron M.
    Shioda, Tatsuo
    Arase, Hisashi
    CELL, 2021, 184 (13) : 3452 - +
  • [27] Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
    Samrat, Subodh Kumar
    Tharappel, Anil M.
    Li, Zhong
    Li, Hongmin
    VIRUS RESEARCH, 2020, 288
  • [28] Immunological Response to Subcutaneous and Intranasal Administration of SARS-CoV-2 Spike Protein in Mice
    Kinoshita, Mao
    Muranishi, Kentaro
    Kawaguchi, Ken
    Sudo, Kazuki
    Inoue, Keita
    Ishikura, Hiroyasu
    Sawa, Teiji
    VACCINES, 2024, 12 (04)
  • [29] SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration
    Idrees, Danish
    Kumar, Vijay
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 554 : 94 - 98
  • [30] Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2
    Maeda, Yosuke
    Toyoda, Mako
    Kuwata, Takeo
    Terasawa, Hiromi
    Tokugawa, Umiru
    Monde, Kazuaki
    Sawa, Tomohiro
    Ueno, Takamasa
    Matsushita, Shuzo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)